XOMA Royalty

Performance

About XOMA Royalty

XOMA Royalty operates as a biotech royalty aggregator, acquiring the economic rights to future milestone and royalty payments tied to partnered pre-commercial clinical candidates. The company provides non-dilutive, non-recourse funding to selling biotech firms to advance their internal drug candidates. With a portfolio of 120+ assets, XOMA Royalty focuses on monetizing royalties and milestone streams from licensed assets developed by others, enabling funding for continued development. The organization positions itself at the intersection of biotech innovation and capital efficiency, serving the pharmaceutical and biotech sectors globally.